Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview
Go back to Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 25.97 +0.77 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.20 | 52 Week High | $42.49 | |||
| Open | $25.41 | 52 Week Low | $16.64 | |||
| Day High | $26.23 | P/E | N/A | |||
| Day Low | $25.13 | EPS | $-0.42 | |||
| Volume | 1,586,385 | |||||
